The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly begin another action to support working groups on « Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration ».
The aim of the call is to establish a limited number of transnational, JPND-sponsored expert working groups to address issues of key relevance for the future use of brain imaging techniques in ND research. Each working group can bid up to €50,000 for support of its activities, which are expected to run for a maximum of 6 months.
This will be a 1-step call, anticipated to launch in early January 2016, with a likely submission deadline of March 2016. Further details will be provided on the call launch date in January 2016. However, any new ideas to tackle harmonisation and alignment in brain imaging will be welcome. For example, this may include:
- Harmonisation of acquisition for current markers (acquisition and harmonisation of procedures, for example, for MR, FDG PET, and EEG signals)
- Simplification of web access to image analysis environments (improving the secure access to innovative web-based image analysis environments for neurodegenerative diseases)
- Innovative PET molecular markers (fostering the use of established and experimental PET methods)
- Innovative ultra-high field (UHF) MR markers
- Proposals are not limited to these topics, and may cover other topics within harmonisation and alignment of brain imaging methods.
- All information regarding future JPND Call topics is subject to change.
- Final call information will be published on the JPND website (www.jpnd.eu).
The diseases covered by JPND are:
– Alzheimer’s disease (AD) and other dementias
– Parkinson’s disease (PD) and PD‐related disorders
– Prion disease
– Motor neurone diseases (MND)
– Huntington’s Disease (HD)
– Spinocerebellar ataxia (SCA)
– Spinal muscular atrophy (SMA)